Publications by authors named "Harm Snippe"

Claim this Profile
G
Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma.
Chiea Chuen Khor, Tan Do, Hongyan Jia, Masakazu Nakano, Ronnie George, Harm Snippe

Nat Genet· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Blended Intervention for Patients With Knee and Hip Osteoarthritis in the Physical Therapy Practice: Development and a Pilot Study.
Daniël Bossen, Corelien Kloek, Harm Wouter Snippe, Joost Dekker, Dinny de Bakker

JMIR Res Protoc· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active patient participation in the development of an online intervention.
Inge Renske van Bruinessen, Evelyn M van Weel-Baumgarten, Harm Wouter Snippe, Hans Gouw, Josée M Zijlstra

JMIR Res Protoc· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles.
Fabrizio Chiodo, Marco Marradi, Boris Tefsen, Harm Snippe, Irma van Die

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.
Dodi Safari, Marco Marradi, Fabrizio Chiodo, Huberta A Th Dekker, Yulong Shan, Harm Snippe

Nanomedicine (Lond)· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope.
Dodi Safari, Huberta A T Dekker, Ger T Rijkers, Arie van der Ende, Johannis P Kamerling, Harm Snippe

Glycoconj J· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region.
Eileen Png, Anbupalam Thalamuthu, Rick T H Ong, Harm Snippe, Greet J Boland

Hum Mol Genet· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization.
Dodi Safari, Huberta A Th Dekker, Ben de Jong, Ger T Rijkers, Johannis P Kamerling, Harm Snippe

Vaccine· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
Dodi Safari, Huberta A Th Dekker, Ger Rijkers, Harm Snippe

Vaccine· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.
Dodi Safari, Huberta A T Dekker, John A F Joosten, Dirk Michalik, Adriana Carvalho de Souza, Harm Snippe

Infect Immun· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.
David Tarragó, Julio Casal, Jesús Ruiz-Contreras, J Tomás Ramos, Pablo Rojo, Harm Snippe

Clin Diagn Lab Immunol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-chain oligosaccharide protein conjugates as experimental pneumococcal vaccines.
W T M Jansen, Harm Snippe

Indian J Med Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
Dirk J Lefeber, Barry Benaissa-Trouw, Johannes F G Vliegenthart, Johannis P Kamerling, Wouter T M Jansen, Harm Snippe

Infect Immun· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis